Proleukin Lyophilisate For Solution For Injection 22000000iu Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Proleukin: Lyophilisate for solution for injection (22000000IU)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ALDESLEUKIN, IL-2 (al des LOO kin) is a chemotherapy drug. It is usually used for advanced renal cell cancer or for advanced melanoma. It is sometimes used for other cancers.

In-Depth Information
Select a Medication

Proleukin 22,000,000units Powder for Injection

NDC: 000780495
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Leprosy (Hansen's Disease), Acute Myelogenous Leukemia (AML), Malignant Melanoma, Mycosis Fungoides, Renal Cell Cancer, Cutaneous T-cell Lymphoma (CTCL), Graft-versus-host Disease (GVHD)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in carton until time of use
Proleukin 22,000,000units Powder for Injection

Reported Side Effects for Proleukin 22,000,000units Powder for Injection

Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High White Blood Cells Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low Body Temperature Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hole In Intestines Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Intestinal Bleeding Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fluid In Lungs Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Paranoia Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Vomiting Of Blood Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hypoxia Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Delirium Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Suddenly Stopped Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Heart Block Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fluid Around The Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Irritated Blood Vessels Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Malignant Hyperthermia Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Kidney Damage Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Uric Acid Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Infection Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Low Platelet Count Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Confusion Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Rapid Heart Rate Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Psychosis Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Electrolyte Imbalance Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Coagulopathy Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Breathing Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Not Breathing Incidence:
1.0-3.0%*
Severity: SEVERE
Onset: RAPID
Loose Stools Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Coma Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
High Bilirubin Level Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Acute Lung Injury Incidence:
3.0-11.0%*
Severity: SEVERE
Onset: EARLY
Low Blood Pressure Incidence:
3.0%*
Severity: SEVERE
Onset: RAPID
Inability To Urinate Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Urination Incidence:
6.0-63.0%*
Severity: SEVERE
Onset: EARLY
Rhinitis Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
11.0%*
Severity: MILD
Onset: DELAYED
Low Calcium Levels Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
12.0%*
Severity: MILD
Onset: DELAYED
Low Magnesium Levels Incidence:
12.0%*
Severity: MODERATE
Onset: DELAYED
Peripheral Vasodilation Incidence:
13.0%*
Severity: MODERATE
Onset: RAPID
Swelling Incidence:
15.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
16.0%*
Severity: MILD
Onset: DELAYED
Exfoliative Dermatitis Incidence:
18.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
>20.0%*
Severity: MILD
Onset: DELAYED
Mouth Ulcers Incidence:
22.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
22.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
23.0%*
Severity: MODERATE
Onset: RAPID
Weakness Incidence:
23.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
24.0%*
Severity: MILD
Onset: RAPID
Feeling Sick Incidence:
27.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
28.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
35.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
42.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
52.0%*
Severity: MILD
Onset: RAPID
Antibody Formation Incidence:
66.0-74.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Proleukin 22,000,000units Powder for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Proleukin 22,000,000units Powder for Injection(Aldesleukin)
Alcohol and Aldesleukin(Aldesleukin)
It is recommended that you do not drink Alcoholic beverages while receiving Aldesleukin, IL-2 therapy. Aldesleukin can cause mood problems, severe drowsiness and other neurologic effects, and can affect the liver. Alcohol could contribute to such side effects.
Moderate Lifestyle Interaction
Marijuana and Proleukin 22,000,000units Powder for Injection(Aldesleukin)
Marijuana and Aldesleukin(Aldesleukin)
Aldesleukin, IL-2 can theoretically decrease the elimination of Marijuana, Medical from the body. Side effects from Marijuana, Medical may worsen if you take Aldesleukin, IL-2. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Proleukin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5